Laparoscopy has become the gold standard approach to cholecystectomy since its introduction 30 years ago, and is one of the most commonly performed general surgical procedures \[[@CR1]\]. Despite the advantages of laparoscopy, however, up to a five-fold increase in rates of bile duct injury (BDI) was reported at the onset of the era of laparoscopic cholecystectomy (LC) \[[@CR2]\]. Relatively high rates of BDI continue to be conveyed, with individual reports ranging from 0.2 to 1.5% \[[@CR3]--[@CR7]\] suggesting that little improvement in outcomes has occurred since the introduction of LC. This compares unfavorably to the era of open surgery, where BDI rates of 0.1--0.2% were commonly accepted \[[@CR2]\].

BDI has a substantial negative impact on patient survival, \[[@CR8], [@CR9]\] is associated with impaired quality of life, \[[@CR10]\] and represents a major source of litigation cost in many modern health systems \[[@CR11]\]. It, therefore, remains a critical goal to reduce rates of BDI, which still is the most feared complication of this common procedure conducted for benign disease.

The only previous study to analyze LC outcomes on a broad scale was an early review published in 1996 by Shea et al. \[[@CR12]\] which pooled data for 78,747 patients from 98 studies. They found an overall collective BDI rate that ranged from 0.36 to 0.47%.

An updated comprehensive understanding of modern-day practice including morbidity and BDI rates, and any factors which may predispose or prevent complications, is necessary if practice is to be improved.

The aims of this review are twofold: (1) to describe current incidence and trends for BDI and other complications during and after LC, and (2) to identify risk factors and preventative measures associated with morbidity and BDI.

Methods {#Sec1}
=======

Search strategy {#Sec2}
---------------

A systematic review was conducted in accordance with PRISMA guidelines for the reporting of systematic reviews and meta-analysis of observational studies \[[@CR13]\]. PubMed, MEDLINE, and Web of Science database searches and data extraction were conducted from 1987 (first published report of laparoscopic cholecystectomy) to January 2015. The following search terms and MeSH headings were used and combined with AND operands: "cholecystectomy," "morbidity," "laparoscopy." Following de-duplication, initial titles and abstracts were reviewed to identify articles of potential interest; these were then retrieved in full-text format for review and data extraction by three independent researchers. Any discrepancies during the search were discussed and revised until consensus was reached.

Selection criteria {#Sec3}
------------------

Studies were included only if they reported detailed individual complications and complication rates. Complications were recorded as defined by the individual study authors. An "all comers only" approach to inclusion in this review was applied, with the aim of including data representative of routine practice of LC (at time of publication) in the general population. As such, studies of select cohorts, such as analyses of LC in acalculous cholecystitis or in geriatric populations, were excluded. Studies were required to include at least 100 subjects, and those explicitly describing early case experience or learning curves were not included to ensure that data were representative of an established practice. Reports where techniques other than conventional multi-port LC (e.g., single incision; robotic) were described were included only if the technique reported represented standard practice for the reporting center or were reported within the context of a randomized trial. This approach was chosen to reduce the risk of selection bias from these studies. When two or more studies shared overlapping data sources, only one study was included according to the following prioritization criteria: (1) the most detailed relevant outcomes, (2) the largest patient population, and (3) the most recent dataset. Study, patient, procedure, and outcome variables were extracted.

Data analysis {#Sec4}
-------------

Descriptive and outcomes data were pooled. Ranges were calculated for pooled major outcomes, taking into account that a lack of a reported outcome did not necessarily mean its absence. For these, either only studies that explicitly reported a given outcome (higher outcome range) were used, or alternatively, all studies were included and assumed a 0% rate for those that did not report the outcome in question (lower range, i.e., "best case scenario"), replicating prior methodology \[[@CR12]\]. Unadjusted analysis of morbidity and BDI rates over time was conducted with studies grouped into 5-year intervals, based on the last reported year of data collection.

To identify underlying factors potentially associated with variation in LC outcomes across studies, meta-regression analysis was conducted for conversion, morbidity, and BDI rates, adjusting for the following co-variates: (1) data year (as represented by the latest year of included data), (2) country of origin (developed vs. developing country according to United Nations human development index classification \[[@CR14]\]), (3) academic *vs*. non-academic center, (4) acute cholecystectomy rate, (5) cholecystitis rate, (6) intraoperative cholangiogram rate, and (7) surgical technique (e.g., standard multi-port LC, single incision LC; each technique separately coded).

Given the inclusion of several studies assessing interventions to reduce BDI, secondary meta-analysis was performed for these papers, but was not included in the main text of this manuscript as the search strategy was not set up to capture these papers and large heterogeneity of data could be expected. Analysis was performed using Stata 12 (StataCorp, Austin, TX), using metan and metareg commands.

Study quality assessment {#Sec5}
------------------------

Study quality was assessed using the Newcastle-Ottawa Scale \[[@CR15]\] for cohort studies, and the Cochrane Collaboration's Risk of Bias Assessment Tool for randomized trials \[[@CR16]\]. Publication bias for BDI rates was assessed using funnel plots with pseudo-confidence intervals,\[[@CR17]\] and Egger's test.

Results {#Sec6}
=======

Search results {#Sec7}
--------------

A total of 12,848 search results were returned and screened for eligibility (Fig. [1](#Fig1){ref-type="fig"}). Following review of title and abstracts, full-text versions of 209 articles were retrieved and reviewed in full. Of these, 151 were included in the final qualitative and quantitative analysis (see appendix 1 for full list).

Fig. 1Literature search flow diagram

A total of 505,292 patients were included in the 151 analyzed studies, which included 18 randomized trials (4549 patients), 117 single center cohort studies (115,237 patients), and 35 multi-center cohort studies (385,506 patients), with a median of 435 patients per study \[interquartile range (IQR) 152--1353\].

Pooled outcomes {#Sec8}
---------------

BDI was divided into major bile duct injuries (as defined by individual authors) and bile leaks in 65 (43%) of studies, representing 170,059 patients. For these patients, overall reported prevalence of major injury was 0.28% and bile leak 0.46%. The remaining studies reported BDI without indication of severity or anatomy. Overall, the pooled range for any biliary injury was 0.32--0.52%, with overall morbidity and mortality of 1.6--5.3 and 0.08--0.14%, respectively (Table [1](#Tab1){ref-type="table"}). Overall pooled prevalences for individual complications are shown in Table [2](#Tab2){ref-type="table"}.

Table 1Pooled outcome data for all included studiesOutcomePooled rangeStudies reportedPatients reportedBile duct injury0.32--0.52%106 (70.1%)307,788 (60.9%)Morbidity1.6--5.3%79 (52%)156,009 (30.9%)Mortality0.08--0.14%71 (46.7%)305,457 (60.5%)IOC rate5.69--26.3%55 (36.2%)109,202 (21.6%)Conversion rate4.2--6.2%130 (85.5%)347,803 (68.8%)Note range of values indicates possible outcome rates if either including only studies explicitly reporting the given outcome, or assuming a 0% rate for a given outcome if not reported in pooled values*IOC* intraoperative cholangiogram

Table 2Pooled data for reported complications other than bile duct injury after laparoscopic cholecystectomyComplication typePrevalence (%)Studies reportedPatients reportedWound infection1.2584 (55.3%)122,963 (24.3%)Urinary retention0.9025 (16.4%)25,863 (5.1%)Bleeding0.7986 (56.6%)146,712 (29%)Retained CBD stones0.5045 (29.6%)111,674 (22.1%)Respiratory0.4840 (26.3%)91,179 (18%)Cardiac0.3632 (21.1%)50,862 (10.1%)Intraabdominal abscess0.3438 (25%)60,517 (12%)Hernia0.2133 (21.7%)58,849 (11.6%)Bowel injury0.1544 (28.9%)99,102 (19.6%)Sepsis0.1420 (13.2%)65,123 (12.9%)Pancreatitis0.1418 (11.8%)39,453 (7.8%)DVT/PE0.1314 (9.2%)18,070 (3.6%)Prolonged ileus0.0417 (11.2%)54,150 (10.7%)*CBD* common bile duct, *DVT*/*PE* deep vein thrombosis/pulmonary embolus

Trends over time {#Sec9}
----------------

Unadjusted analysis demonstrated a statistically significant reduction in reported BDI from 0.69% (0.52--0.84) to 0.22% (0.02--0.40) (mean and 95% confidence interval (CI)) (*p* = 0.011) for the intervals 1994--1999 and 2010--2014, respectively. There was no statistically significant difference for conversion rates (pooled range 4.2--6.2%, *p* = 0.269), or morbidity rates (1.6--5.3%, *p* = 0.931) across time periods (Fig. [2](#Fig2){ref-type="fig"}).

Fig. 2Boxplots for **A** bile duct injury rates, **B** morbidity rates, and **C** conversion rates, for each 5-year interval of included data

Meta-regression analysis {#Sec10}
------------------------

Multi-variate adjusted (meta-regression) analysis (Table [3](#Tab3){ref-type="table"}) found few detectable differences in BDI or morbidity rates. For conversion rates, LC in developing countries were less likely to be converted to open (mean 3.4 vs. 4.7%, *p* = 0.026).

Table 3Results of meta-regression analysisOutcomeVariableCoefficientLower 95% CIUpper 95% CIp valueBDI rateData year− 0.009− 0.0470.0270.602Academic center0.165− 0.2250.5560.403Acute cholecystectomy rate1.318− 5.9228.5590.699Cholecystitis rate− 0.701− 4.6223.2200.718IOC rate0.061− 0.7770.8990.883Surgical technique0.496− 0.3081.2990.224Country of origin− 0.002− 0.4350.4320.994Morbidity rateData year0.0166− 0.0160.0490.319Academic center0.256− 0.1340.6450.195Acute cholecystectomy rate2.231− 1.2395.7020.191Cholecystitis rate− 1.009− 5.6493.6310.659IOC rate0.249− 0.7871.2850.625Surgical technique− 0.453− 1.2770.3730.278Country of origin0.324− 0.1890.8360.213Conversion rateData year− 0.017− 0.0400.0060.149Academic center− 0.083− 0.3540.1870.545Acute cholecystectomy rate1.621− 0.6653.9060.152Cholecystitis rate− 0.982− 3.8391.8750.493IOC rate0.322− 0.3661.0100.351Surgical technique− 0.13− 0.7760.5160.692Country of origin^a^0.3460.0410.6520.026*BDI* bile duct injury, *CI* confidence interval, *IOC* intraoperative cholangiogram^a^*p* \< 0.05

Considering studies that assessed the effects of interventions on LC outcomes, reporting was heterogenous and quality of studies suitable for meta-analysis was poor. No more than two studies reported comparable outcomes for any given intervention, precluding any meaningful meta-analysis or interpretation of results; these are, therefore, not further discussed in this paper, though results are included for completeness (see Appendix 2).

Study quality and bias {#Sec11}
----------------------

Overall quality of the included studies was moderate. Newcastle-Ottawa scores for cohort studies were (mean ± standard deviation) 6.2 ± 1.0, range 4--9. Risk of bias for randomized trials using the Cochrane Collaboration tool was generally low (Appendix 1). The rate of outcome reporting was highly variable and is reported in Table [4](#Tab4){ref-type="table"}.

Table 4Rates of demographic and outcome data reporting by included studiesStudies reportedPatients reportedConversion rate130 (85.5%)347,803 (68.8%)Gender119 (78.3%)207,071 (41%)Age111 (73%)217,607 (43.1%)BDI106 (71%)307,788 (60.9%)Technique84 (55.3%)93,035 (18.4%)Morbidity79 (52%)156,009 (30.9%)Duration of hospital stay75 (49.3%)224,955 (44.5%)Mortality71 (46.7%)305,457 (60.5%)Operative time69 (45.4%)79,452 (15.7%)IOC rate55 (36.2%)109,202 (21.6%)Cholecystitis rate35 (23%)51,749 (10.2%)BMI23 (15.1%)27,567 (5.5%)Acute cholecystectomy18 (11.8%)42,866 (8.5%)*BDI* bile duct injury, *IOC* intraoperative cholangiogram, *BMI* body mass index

Publication bias for BDI rates using funnel plots and pseudo-confidence intervals are found in Figs. [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"}. Use of Egger's test suggested statistically significant bias (bias coefficient 1.87 ± 0.34, *p* \< 0.001). Bias risk for reported conversion rates was also assessed for developed (0.13 ± 1.02, *p* = 0.898) and developing countries (1.42 ± 1.02, *p* = 0.178) of origin.

Fig. 3Funnel plot for bile duct injury rates

Fig. 4Comparison of funnel plots for conversion rates for developing (left) and developed (right) countries

Discussion {#Sec12}
==========

This review of outcomes for LC reconfirms the established principle that LC is safe and may be performed with minimum morbidity (pooled prevalence range 1.6--5.3%) and mortality (0.08--0.14%). LC remains the unchallenged gold standard, with conversion rates between 4.2 and 6.2%.

BDI outcomes analysis was limited by the fact that BDI was not universally reported and different classifications were used (without any formalized correspondence as to the grading); we were, therefore, unable to segregate bile leaks according to severity or nature of injury. Our findings, however, are consistent with recent Swedish population analyses of over 51,000 LCs which reported a 0.3% major BDI rate, \[[@CR18]\] with an overall 1.5% bile leak rate \[[@CR7]\]. At 0.32%, the lower estimate of pooled BDI rate in our overall analysis remained higher than the commonly accepted rates of 0.1--0.2% for open cholecystectomy reported at the dawn of the laparoscopic era over a quarter century ago \[[@CR2]\]. Unadjusted pooled outcomes in our study suggested a modest decrease in reported BDI rates over the past 30 years. However, this was not reflected in the meta-regression analysis. Regardless, with nearly 1 million cholecystectomies performed per year in the United States alone, \[[@CR19]\] the medical, psychological, and socioeconomic burdens represented by BDI remain substantial. This consideration is particularly true if one weighs it in the context of LC as an extremely common, and, by today's standards, a typically outpatient or short stay procedure performed for benign disease. Furthermore, a large volume of performed LC are probably not included in any studies and their complication rate may be higher than the ones presented here. Yamashita et al., for example, reported Japanese national survey data suggesting little change in BDI rates over the past decade, with a mean incidence of 0.66% \[[@CR20]\].

Technological and technical efforts to improve LC quality continue. However, despite the growing number of methods intended to reduce BDI, the evidence for their ability to impact BDI rates remains limited. A 2011 systematic review of interventions to prevent BDI identified a number of candidate techniques and procedures, including routine use of the critical view of safety approach and intraoperative cholangiography, but conclusive effects on BDI rates could not be shown \[[@CR21]\]. In addition, series which have examined the mechanism of biliary injury have rarely described use of the critical view of safety as the method of ductal identification \[[@CR22], [@CR23]\]. However, several large retrospective series in which the critical view of safety was used routinely have been reported with no biliary injuries \[[@CR24], [@CR25]\].

A major challenge for assessing factors associated with BDI risk is its relatively low prevalence (0.3--0.5%). A study assessing a procedure to reduce BDI rates would, for example, require a sample size of 16,989 patients in each arm to detect a 50% reduction of the BDI rates from 0.3% (assuming a standard alpha = 0.05 at 80% power). The logistical obstacles and confounders involved in a study of this size means such a trial is highly unlikely to take place. Moreover, the true prevalence of BDI is difficult to ascertain from the literature, as there is wide confusion between prevalence and incidences in reports. Instead, we must, therefore, rely on cohort, expert, and surrogate data, such as the ability to accurately demonstrate and identify biliary anatomy intraoperatively, as is the aim with the critical view of safety, and other methods of ductal identification \[[@CR26], [@CR27]\]. Newer techniques such as infrared fluorescence cholangiography are generating considerable interest as a way to enhance identification of the anatomy during cholecystectomy, but must be evaluated by further study in larger numbers of patients before any recommendations can be made \[[@CR28]\].

In the present study, we assessed the effect of technical, patient, and hospital characteristics on BDI rates. These factors had few detectable associations with BDI rates. It is crucial, therefore, to recognize the role that education, decision-making, and experience have to play in preventing BDI during LC. A recent insurance database review study of BDI illustrated the effect of surgeon experience and volume, wherein younger, less experienced surgeons reported BDI rates three times higher than their more experienced counterparts \[[@CR29]\]. A European-based population study has suggested that a positive volume--outcome relationship for LC exists with reference to outcomes other than BDI as well, with high volume centers (defined as \> 244 LC/year) reporting lower morbidity, mortality, and reoperation rates \[[@CR30]\].

Data published by Way et al., \[[@CR31]\] in which root causes of over 200 BDIs were identified, highlighted the fact that over 97% of errors were related to non-technical, predominantly perceptual errors. In response to this and other data, a recent international Delphi consensus study headed by the Society for American Gastrointestinal Endoscopic Surgeons (SAGES) Safe Cholecystectomy Task Force identified the most important factors to safety in LC as (1) establishing the CVS, (2) understanding of anatomy, (3) adequate exposure, (4) ability to call a senior colleague for help, and (5) recognizing when to convert or abandon \[[@CR32]\]. Education and practice, the group recommended, should be focused around these key principles, with technical factors such as choice of dissection tool, duct securing technique, or use of cholangiography ranking lower in priority.

This review and its conclusions are subject to several limitations. As discussed, we had limited statistical power to identify differences in BDI rates by a range of factors because of its relatively low prevalence and/or incidence rates. Secondly, we imposed minimum sample sizes to reduce the risk of selection bias from smaller studies. This approach may have had the effect of excluding studies that might otherwise have been included in secondary outcome analyses, and meant that no more than two studies were available for analysis of each assessed intervention. It was, however, our expressed aim to focus on BDI and complication rates and numerous other reviews (including those already cited) for individual interventions and secondary outcomes exist which incorporated smaller studies not included here. The ranges reported here for pooled outcomes reflect the inconsistency of data reporting, even for large-scale studies focused on outcomes for LC. For the lower range, assuming a 0% prevalence or incidence for studies which did not report a given outcome will invariably underestimate the pooled rate as it combines studies which did not report prevalence/incidence due to a true 0% rate, with those with incomplete outcomes reporting. Interpretation of our findings must take this aspect into account.

In addition, it is almost certain that many BDI are neither reported nor published except for national database reporting requirements such as in Sweden, and therefore, the true prevalence/incidence of BDI in most of the world is not precisely known and may be higher than identified herein. Administrative databases accounted for a large proportion of the retrospective studies included here; their advantageous large numbers are tempered by the fact that they likely lack detailed coding with reference to prevalence/incidence of BDI, and do not allow differentiation between types of injury. Further, if BDIs are recorded without severity, based on reoperation (hepaticojejunostomy) alone, this surrogate endpoint presents the dual problem of skewing injuries to the severe end of the scale, as well as underestimating overall injury rates---potentially accounting in part for the apparent reduction observed in our pooling of recent data of BDI.

Although our inclusion criteria aimed to maintain high overall study quality, the thoroughness of outcomes reporting was highly variable. In many cases, the quality of reporting in recent literature was worse than 20 years ago; duration of stay and morbidity were reported for 49 and 52% of studies included, respectively, compared to 82 and 98% in the previous 1996 analysis by Shea et al. \[[@CR12]\]. This finding highlights the need for standardized reporting of outcomes for these procedures \[[@CR33]\]. Finally, analysis of funnel plots suggested significant publication bias. This finding potentially also accounts for the differences seen in conversion rates between developed and developing countries, with a much higher bias coefficient seen in developing countries.

Future advances to improve outcomes in LC will need to consider technological, educational, and structural approaches. Technological developments offer new techniques for the identification of biliary anatomy but have limited evidence demonstrating their effectiveness. Though some show promise, it is unlikely that interventions will be able to detect an effect on BDI within the context of a randomized trial due to limitations of sample size. It is incumbent upon researchers, therefore, to identify and focus on selected surrogate outcome measures, and particularly to ensure the standardization of reporting, for example including complications, BDI, and ductal injury type, which continues to elude LC-related research. The establishment of international registries should be prioritized.

Education, training, and mentorship, with emphasis on techniques such as the critical view of safety, will continue to be the mainstay of surgical expertise. Modern teaching paradigms have enhanced educators' understanding of the often unconsciously carried knowledge which constitutes surgical expertise, with teaching frameworks designed to reveal and convey these to learners \[[@CR34]\]. Aided by technological teaching adjuncts, including virtual reality and box trainers, these have the potential to accelerate improvement and abbreviate learning curves \[[@CR35]\]. The technology, training, and expertise required for LC, coupled with the severity of BDI as a potential complication, calls for a reassessment of how LC is taught and what educational strategies could be used to impact this problem.

Conclusions {#Sec13}
===========

This extensive systematic review and pooled data analysis summarizes the current body of knowledge relating to outcomes following laparoscopic cholecystectomy. It could represent a useful benchmark against which clinicians and health systems may measure outcomes, with which patients may weigh the risks of surgery, and against which researchers may assess their data reporting.

No definitive intervention to reduce BDI rates was identified, which likely reflects the limitations of the data reported in these various studies. Overall, we report marginal, if any, reductions in the rate of reported BDI. Pooled rates for BDI after LC remain higher than during the era of open cholecystectomy. Given the high prevalence of cholecystectomy, thousands of patients per year continue to sustain BDI, with severe and long-term implications for their health, underscoring once again the need to continue research in this field, and to inform and educate young surgeons concerning the risk and consequences of BDI during LC.
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